Salvioli Stefano, Capri Miriam, Bucci Laura, Lanni Cristina, Racchi Marco, Uberti Daniela, Memo Maurizio, Mari Daniela, Govoni Stefano, Franceschi Claudio
Department of Experimental Pathology, University of Bologna, Bologna, Italy.
Cancer Immunol Immunother. 2009 Dec;58(12):1909-17. doi: 10.1007/s00262-008-0639-6. Epub 2009 Jan 13.
Centenarians are exceptionally long living individuals who escaped the most common age-related diseases. In particular they appear to be effectively protected from cancers. The mechanisms that underlie this protection are quite complex and still largely unclear.
To critically analyse the literature in order to propose a unifying hypothesis that can account for this cancer protection in centenarians.
Review of the scientific literature regarding three main players in tumourigenesis such as IGF-1, inflammation and p53, and centenarians.
Centenarians appear to be characterised by low IGF-1-mediated responses and high levels of anti-inflammatory cytokines such as IL-10 and TGF-beta, a condition that results in protection from cancer. Both inflammation and IGF-1 pathway converge on the tumour suppressor p53. Accordingly, some studies indicate that genetic variants of p53 are associated with human longevity by providing protection from cancer mortality.
The available data let us to hypothesise that among other possible mechanisms, well-preserved p53-mediated responses are likely a key factor contributing to protection from cancer in centenarians.
百岁老人是特别长寿的个体,他们逃过了最常见的与年龄相关的疾病。特别是,他们似乎能有效抵御癌症。这种保护作用背后的机制相当复杂,在很大程度上仍不清楚。
批判性地分析文献,以提出一个能解释百岁老人这种癌症保护作用的统一假说。
回顾关于肿瘤发生过程中三个主要因素(如胰岛素样生长因子-1、炎症和p53)以及百岁老人的科学文献。
百岁老人的特征似乎是胰岛素样生长因子-1介导的反应较低,以及抗炎细胞因子(如白细胞介素-10和转化生长因子-β)水平较高,这种情况导致对癌症的保护。炎症和胰岛素样生长因子-1途径都汇聚于肿瘤抑制因子p53。因此,一些研究表明,p53的基因变异通过提供对癌症死亡的保护而与人类长寿相关。
现有数据使我们推测,在其他可能的机制中,保存完好的p53介导的反应可能是百岁老人抵御癌症的一个关键因素。